A46 Erysipelas

Name of the Condition

• Erysipelas

Summary

Erysipelas is an acute, superficial bacterial skin infection characterized by well-demarcated, raised, and painful erythematous plaques. The condition typically involves the dermis and superficial lymphatics, often presenting with systemic symptoms such as fever and chills. It is most commonly caused by Streptococcus pyogenes and may progress rapidly if untreated.

Causes

Erysipelas is primarily caused by infection with Streptococcus pyogenes (group A streptococcus). The bacteria enter the skin through breaks or abrasions, such as cuts, insect bites, or ulcers, leading to localized inflammation and tissue damage. Less commonly, other streptococcal species or Staphylococcus aureus may be involved.

Risk Factors

• Skin trauma or breaks (e.g., cuts, burns, or surgical wounds)
• Lymphedema or impaired lymphatic drainage
• Chronic skin conditions (e.g., eczema or athlete’s foot)
• Diabetes or immunocompromised states
• Advanced age or alcohol use disorder

Symptoms

• Rapidly spreading, raised red patches with sharp borders
• Pain, warmth, and swelling at the affected site
• Fever, chills, or malaise
• Blisters or bullae in severe cases
• Lymph node enlargement near the infection

Diagnosis

Diagnosis is based on clinical presentation, including the characteristic appearance of the rash and associated symptoms. Laboratory testing, such as blood cultures or skin swabs, may be performed to identify the causative organism, especially in severe or recurrent cases. Imaging is rarely needed unless deeper tissue involvement is suspected.

Treatment Options

• Antibiotics: Oral or intravenous antibiotics (e.g., penicillin or macrolides) are the mainstay of treatment, tailored to the suspected pathogen.
• Supportive Care: Rest, elevation of the affected limb, and pain management may aid recovery.
• Wound Care: Keeping the area clean and covered to prevent further infection.

Prognosis and Follow-Up

With prompt antibiotic treatment, most patients recover fully within 1–2 weeks. Follow-up may be recommended to monitor for recurrence or complications, especially in individuals with underlying risk factors. Recurrent episodes may require longer-term preventive measures.

Complications

• Cellulitis (deeper skin infection)
• Abscess formation
• Septicemia (rare, in severe cases)
• Chronic lymphedema or skin changes

Lifestyle & Prevention

• Maintain good skin hygiene and promptly clean any cuts or wounds.
• Treat underlying skin conditions (e.g., athlete’s foot) to reduce entry points for bacteria.
• Avoid sharing personal items (e.g., towels) that may harbor infection.
• Manage chronic conditions like diabetes to support immune function.

When to Seek Professional Help

Seek medical attention if symptoms worsen, spread rapidly, or are accompanied by high fever, chills, or signs of systemic infection. Prompt treatment is critical to prevent complications.

Tips for Medical Coders

Document the clinical findings, including the location and extent of the rash, presence of systemic symptoms, and any underlying risk factors. Ensure the code A46 is used for erysipelas, and specify the affected body site (e.g., leg, face) if required for specificity. Note any complications or recurrent episodes to support accurate coding and clinical context.